Clinical utility of TERT promoter mutations and ALK rearrangement in thyroid cancer patients with a high prevalence of the BRAF V600E mutation

BACKGROUND: Mutations in the TERT promoter, ALK rearrangement, and the BRAF V600E mutation are associated with aggressive clinicopathologic features in thyroid cancers. However, little is known about the impact of TERT promoter mutations and ALK rearrangement in thyroid cancer patients with a high p...

Descripción completa

Detalles Bibliográficos
Autores principales: Bae, Ja Seong, Kim, Yourha, Jeon, Sora, Kim, Se Hee, Kim, Tae Jung, Lee, Sohee, Kim, Min-Hee, Lim, Dong Jun, Lee, Youn Soo, Jung, Chan Kwon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4746931/
https://www.ncbi.nlm.nih.gov/pubmed/26857243
http://dx.doi.org/10.1186/s13000-016-0458-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4746931/
https://www.ncbi.nlm.nih.gov/pubmed/26857243
http://dx.doi.org/10.1186/s13000-016-0458-6

Ejemplares similares